More pharma companies are tailoring their business models to focus on low-income countries. But a new analysis finds overall ...
Ms. Turner brings to LB Pharma over two decades of executive leadership experience in the biotechnology industry, with a proven track record of driving growth and executing high-value transactions.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback